Study Finds Laparoscopic Gastric Bypass Surgery / Bariatric Surgery Better Than Medicine in Controlling Type 2 Diabetes ( NIDDM )
Laparoscopic gastric bypass surgery can be more effective in patients with type 2 diabeteas and obesity. According to a new study presented here at the 25th Annual Meeting of the American Society for Metabolic & Bariatric Surgery (ASMBS), patients with morbid obesity who have bariatric surgery lost significant weight over the long-term and are significantly less likely to die from heart disease, diabetes and cancer. Thus the study finds that the laparoscopic surgery can be more effective than the traditional insulin based treatment.
Researchers from the Gundersen Lutheran Medical Center in La Crosse, Wisconsin analyzed 102 patients with Type 2 diabetes. Half of the patients in the study received conventional medical treatment and the other half had laparoscopic gastric bypass surgery. On average, patients were 48-years-old and had a body mass index (BMI) of 47. At the end of the study, the surgical group recorded A1c levels drop from an average of 7.5 to 5.8 after a year, and to 6.1 after three years while the conventional medical treatment group had an increase in their levels from 7 to 7.8 over the same three years. The vast majority of surgical patients were also able to get off diabetes medications completely. Before surgery, 84.3 percent were on oral medications and/or insulin. One year after surgery, only 22.4 percent still required medication. In contrast, the conventional treatment group had an increase in amount of oral medications and/or insulin taken. The study showed the number of patients on diabetes medication grew from 66.7 percent to 82 percent in one year.
Shanu N. Kothari, MD, FACS, the study’s co-author and the director of Minimally Invasive Bariatric Surgery at the Gundersen Lutheran Medical Center in Wisconsin said, “The data continues to support the effectiveness of bariatric surgery in treating Type 2 diabetes in morbidly obese patients.”
About 64 million or 32 percent of adults in the U.S. are considered obese, which is associated with many other diseases and conditions including type 2 diabetes, heart disease, sleep apnea, hypertension, asthma, cancer, joint problems and infertility. The direct and indirect costs to the healthcare system associated with obesity are about $117 billion annually.
Source: Medical News Today
Filed under Diabetes, Diabetes Drug, NIDDM, Obesity | Tags: American Society for Metabolic & Bariatric Surgery, bariatric surgery, body mass index (BMI), Cancer, Diabetes medication, Heart Disease, Insulin, Laparoscopic gastric bypass surgery, Lost, morbid obesity, Obesity | 1 Comment